WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark mRNACT was filed as Word mark on 10/28/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1660204 |
| Countries | 
|
| Base trademark |
No. 90720622,
May 19, 2021
|
| Application date | October 28, 2021 |
| Expiration date | October 28, 2031 |
Trademark owner
475 Green Oaks Parkway
Holly Springs NC 27540
US
Holly Springs NC 27540
US
Trademark representatives
151 West 42nd Street, 17th Floor
New York NY 10036
US
goods and services
01
Medical, biological, and pharmaceutical preparations for
scientific and research use, or for the manufacture of
pharmaceuticals, namely, preparations containing messenger
RNA for preventing and treating viruses and respiratory
disorders; biochemicals for in vivo, ex vivo, on vivo or in
vitro scientific research and medical research, namely, for
use in the manufacture of pharmaceuticals for preventing and
treating viruses and respiratory disorders; lipid
nanoparticles for scientific, laboratory or medical research
use
05
Vaccines; vaccine adjuvants; medical, biological, and
pharmaceutical preparations for medical use, namely,
preparations containing messenger RNA for preventing and
treating viruses and respiratory disorders; mRNA-based
therapeutics and therapeutic agents for in vivo, ex vivo, or
in situ prevention and treatment of viruses and respiratory
disorders; lipid nanoparticles for pharmaceutical, medical
or diagnostic purposes; drug carriers for medical use,
namely, lipid nanoparticles for delivering drugs; lipid
nanoparticles for drug delivery sold as an integral
component of drugs; pharmaceutical preparations, namely,
messenger RNA and delivery agents comprised of lipid
nanoparticle carriers and polymers for the delivery of mRNA
to human cells; medical, biological, and pharmaceutical
preparations for medical laboratory use, namely,
preparations containing messenger RNA for preventing and
treating viruses and respiratory disorders
42
Pharmaceutical research and development; medical research
services; biotechnology research; scientific research for
medical purposes; design and development of medical
technology; design, engineering, research, and development
services in the field of nucleic acid sciences for medical
and scientific applications; providing medical and
scientific research in the fields of pharmaceuticals and
vaccines
44
Medical services; medical information; providing medical
information via a website
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 12, 2023 | 2023/24 Gaz | NO | Rejection |
| May 12, 2023 | 2023/20 Gaz | LI | Rejection |
| March 22, 2023 | 2023/12 Gaz | CH | Rejection |
| July 20, 2022 | 2022/29 Gaz | AU | Rejection |
| October 28, 2021 | 2022/17 Gaz | US | Registration |
ID: 141660204